“…Observed 1 and 5-year overall survival estimates for Bucaramanga in the special and contributive regimes were similar to relative survival estimates from Denmark, Scotland, Poland and Bulgaria, the lowest estimates within Europe [3,21], but survival for patients affiliated to the subsidized regime or those nonaffiliated to the health insurance system, and patients of low SS was much poorer, comparable to those of the indigenous Mapuches in Chile [20].…”